Oncology Prostate and Urologic Cancers Prostate Biochemical Relapsed Hormone Sensitive
Categories
NRG-GU011
Protocols
ALLIANCE-A032302-ASPIRE Phase III OPEN TO ACCRUAL
Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)